- Home
- TAK vs NDAQ Comparison
TAK vs NDAQ Comparison
Compare TAK & NDAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAK | NDAQ |
|---|---|---|
| Founded | 1781 | 1971 |
| Country | Japan | United States |
| Employees | 47455 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5B | 56.3B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | TAK | NDAQ |
|---|---|---|
| Price | $17.78 | $84.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $104.07 |
| AVG Volume (30 Days) | 2.3M | ★ 4.1M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 2.91% | 1.26% |
| EPS Growth | N/A | ★ 60.10 |
| EPS | N/A | ★ 3.09 |
| Revenue | N/A | ★ $4,277,000,000.00 |
| Revenue This Year | $0.04 | $10.63 |
| Revenue Next Year | $0.92 | $8.13 |
| P/E Ratio | $41.25 | ★ $27.69 |
| Revenue Growth | N/A | ★ 7.87 |
| 52 Week Low | $12.99 | $64.84 |
| 52 Week High | $18.82 | $101.79 |
Technical Indicators
Market Signals| Indicator | TAK | NDAQ |
|---|---|---|
| Relative Strength Index (RSI) | 46.80 | 40.76 |
| Support Level | $17.51 | $78.69 |
| Resistance Level | $18.82 | $90.61 |
| Average True Range (ATR) | 0.24 | 2.54 |
| MACD | -0.15 | 0.41 |
| Stochastic Oscillator | 20.19 | 43.75 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About NDAQ Nasdaq Inc.
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.